Publication | Open Access
Blocking glutamate mGlu<sub>5</sub> receptors with the negative allosteric modulator CTEP improves disease course in SOD1<sup>G93A</sup> mouse model of amyotrophic lateral sclerosis
23
Citations
61
References
2021
Year
Our results suggest that mGlu<sub>5</sub> receptors are promising targets for the treatment of ALS and highlight mGlu5 receptor NAMs as effective pharmacological tools with translational potential.
| Year | Citations | |
|---|---|---|
Page 1
Page 1